Chondromyxoid fibroma is a benign neoplasm developing in bone tissue, diagnosed in very few patients. Research shows that this tumour accounts for only 0.7-1% of all bone cancers. Characteristic signs of the pathology are often poorly expressed in the early stages, which explains the difficulty of timely diagnosis. Thanks to the use of progressive surgical techniques, the treatment of chondromyxoid fibroma in Israel is successfully performed for patients of all age groups. Comprehensive therapy, including the most effective methods for the patient, ensures a favorable prognosis and complete recovery in almost 100% of cases. Postoperative defects are corrected through reconstructive plastic surgery, and after the recovery period, the patient undergoes a full rehabilitation course.
To prescribe an adequate treatment program, a comprehensive diagnostic examination is necessary. Israeli clinics are equipped with the latest technology, allowing for rapid and accurate diagnosis. The diagnosis and treatment of the disease are carried out by highly qualified orthopedic surgeons with many years of experience who regularly undergo internships at leading clinics worldwide. Numerous patient reviews indicate that, with the same quality of medical services, the cost of treatment in Israel is much lower than in Western European countries and the USA.
Treatment methods for the disease
The common method for treating chondromyxoid fibroma is the surgical removal of the neoplasm. Currently, in Israeli clinics, as well as in medical centers of other countries with developed medicine, no other therapeutic methods for this pathology are accepted in clinical practice. Treatment should be conducted as soon as possible, as there is a risk of malignant transformation of the tumour.
The following types of surgical interventions are indicated for the removal of chondromyxoid fibroma:
- Marginal resection of the affected bone fragment — the most effective and safe method for the patient, mainly used in Israeli clinics. The excision of the bone tissue involved in the tumour process is performed without damaging the bone and violating its integrity. The manipulations are carried out in an area limited by healthy, non-pathological tissues. In most cases, when assessing the necessary volume of excision, the surgeon retreats from the neoplasm by at least 5 millimeters. The recommended retreat distance may be greater, depending on the bone in which the chondromyxoid fibroma is localized. If viable cells with pathological changes remain in the bed after the neoplasm is removed, there is a likelihood of recurrence after some time. To prevent this, a larger fragment of bone tissue is excised during the procedure. If the marginal resection operation is performed following all the rules, the risk of recurrence of the fibroma is negligible.
- Curettage — removal of tumour tissues from the affected area of the bone by scraping with a special surgical curette, which resembles a spoon. The only defect that develops after this method of surgical removal of the neoplasm is a small depression in the bone tissue. As practice shows, this method of surgical removal of the tumour carries a high risk of retaining pathologically altered cells, which serve as the cause of recurrence. For this reason, curettage is rarely used in Israeli clinics.
In some cases, sessions of radiation therapy precede the surgical removal of chondromyxoid fibroma. The procedure is indicated because the size of the neoplasm significantly decreases under the influence of ionizing radiation, painful symptoms weaken, and subsequent surgical intervention is facilitated. However, studies have shown that radiation therapy increases the likelihood of malignant transformation of the tumour. For this reason, irradiation is rarely prescribed in Israeli clinics.
For approximately a week after the surgical removal of the fibroma, the patient requires monitoring by doctors. After this period, the patient is discharged from the hospital and referred for a rehabilitation course. The rehabilitation program is individually tailored for each patient and includes physiotherapy aimed at restoring movement disorders in the limb, and medications to strengthen the immune system. For timely diagnosis of possible recurrence of the pathology, regular examinations are recommended for several years after treatment.
Bone deformities of significant size resulting from the surgical removal of chondromyxoid fibroma are corrected using allogeneic or autogenous bone tissue transplantation. In the first case, the patient undergoes transplantation of a fragment of bone from a compatible donor, while autotransplantation involves using a section of healthy bone from the patient himself. Allogeneic transplantation does not require an additional operation to obtain bone material, while the transplantation of the patient's own tissue does not develop rejection reactions and occurs more rapidly.
How the diagnosis of the disease is conducted
If chondromyxoid fibroma is suspected, the patient is referred for a comprehensive diagnostic examination necessary to distinguish the pathology from musculoskeletal diseases with similar symptoms. Additionally, establishing the nature of the neoplasm is required to differentiate it from malignant chondrosarcoma.
The need for a comprehensive examination is also due to the absence of pronounced clinical symptoms. The degree of expression of characteristic signs of the disease depends on the age of the patient. In children, rapid progression of the pathology, the occurrence of severe pain, and impairment of functional abilities of the affected limb are observed. In adulthood, the pathology may proceed asymptomatically for a long period.
In Israeli clinics, thorough diagnostics take, on average, no more than three days.
First day
Upon arrival at the clinic, the patient is referred for a consultation with the attending physician. During the appointment, the doctor reviews the medical history, conducts a physical examination, determines possible causes of the disease, and prescribes necessary examinations.
Second day
Undergoing prescribed examinations, including:
- X-ray — a mandatory examination that allows for the identification and assessment of the pathological focus, establishing its size, which in most cases ranges from 2-7 centimeters in length, and boundaries;
- biopsy — obtaining samples of pathologically altered tissues followed by histological analysis, allowing for the precise determination of the nature of the tumour and distinguishing it from chondrosarcoma.
Third day
A medical council, consisting of the attending physician and several narrow-profile specialists, reviews the obtained examination results, makes a final diagnosis, and develops a treatment program.
How much does treatment of the disease cost
The cost is determined after the patient undergoes examinations and the prescription of treatment procedures. In general, the price of treatment in Israel is 30-50% lower than in Western European and American clinics of the corresponding level.
Advantages of treatment in Israel
- Experienced qualified doctors.
- Accurate diagnostics on high-tech equipment.
- Professional execution of surgical tumour removal.
- Complete elimination of postoperative bone defects and patient rehabilitation.
- Affordable prices.
Effective treatment will allow you to forget about the disease forever, relieve discomfort, and reduce the risk of serious complications. Therefore, upon the appearance of suspicious symptoms, do not hesitate, choose a clinic and start the course of therapy.